Lemaitre Vascular INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
LeMaitre Vascular, Inc. announced robust financial results for 2025, driven by increased sales, improved margins, and strategic expansions, alongside an increased quarterly dividend.
NASDAQ
10-K: LeMaitre Vascular Reports Fiscal Year 2024 Results, Highlights Growth and Strategic Initiatives
LeMaitre Vascular's 2024 10-K filing reveals a year of growth driven by strategic acquisitions, sales force expansion, and increased pricing, alongside ongoing efforts to navigate regulatory landscapes and optimize manufacturing.
NASDAQ
10-K: LeMaitre Vascular Reports Strong 2023 Results Driven by Sales Growth and Strategic Initiatives
LeMaitre Vascular's 2023 annual report highlights a 20% increase in net sales and a 37% rise in operating income, fueled by higher prices, increased procedure volumes, and strategic acquisitions.